Medtronic plc, headquartered in Dublin, is a listed company in the field of medical technology. The company is known for its pacemakers, implantable cardioverter defibrillators, heart valves, insulin pumps, aortic stent grafts, coronary stents and neurostimulators. Medtronic manufactures more than half of all pacemakers implanted worldwide.
According to Medtronic's latest financial reports and stock price the company's current number of shares outstanding is 1,281,600,000. At the end of 2025 the company had 1,281,600,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.